Avapritinib Market In Global
Avapritinib is a potent and selective inhibitor of exon 17 mutant KIT.
This report ... Read More
Atractylenolide I is a sesquiterpene that has been found in the rhizomes of A. macrocephala and has diverse biological activities, including anti-inflammatory, anti-angiogenic, anti-tumor, and antidepressant properties.
This report contains market size and forecasts of Atractylenolide I in global, including the following market information:
Global Atractylenolide I Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Atractylenolide I Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Atractylenolide I companies in 2021 (%)
The global Atractylenolide I market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Atractylenolide I include Merck, Selleck Chemicals, Cayman Chemical, AbMole, Biorbyt, BioVision, BOC Sciences, MuseChem and Taiclone, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Atractylenolide I manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Atractylenolide I Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Atractylenolide I Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Atractylenolide I Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Atractylenolide I Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Atractylenolide I Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Atractylenolide I Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Atractylenolide I revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Atractylenolide I revenues share in global market, 2021 (%)
Key companies Atractylenolide I sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Atractylenolide I sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Selleck Chemicals
Cayman Chemical
AbMole
Biorbyt
BioVision
BOC Sciences
MuseChem
Taiclone
APExBIO Technology
J&K Scientific
Avapritinib is a potent and selective inhibitor of exon 17 mutant KIT.
This report ... Read More
Ganoderic acid A is a triterpene that has been found in Ganoderma and has diverse biological acti ... Read More
Angelicin is a constituent of roots and leaves of angelica with anti-inflammatory activity and re ... Read More
Peiminine is an alkaloid that has been found in Fritillaria and has diverse biological activities ... Read More